# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Jun 18, 2024

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2024-06-18
- Accepted by EDGAR: Jun 18, 2024, 16:47 ET
- Period: 2024-06-14
- Accession: 0001787306-24-000090
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000178730624000090/arqt-20240614.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000178730624000090/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000178730624000090/arqt-20240614.htm

Filed Jun 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001787306-24-000090. Last ingested by Listed: Nov 2, 2026, 20:20 ET. No prices; not investment advice.